Daniel P Holschneider1, Zhuo Wang1, Huiyi Chang2,3, Rong Zhang2, Yunliang Gao2,4, Yumei Guo1, Jackie Mao2, Larissa V Rodriguez2. 1. Departments of Psychiatry and Behavioral Sciences, Los Angeles, California. 2. Department of Urology, University of Southern California, Los Angeles, California. 3. Reeve-Irvine Research Center, University of California, Irvine, California. 4. Department of Urology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
Abstract
AIMS: Emotional stress plays a role in the exacerbation and development of interstitial cystitis/bladder pain syndrome (IC/BPS). Given the significant overlap of brain circuits involved in stress, anxiety, and micturition, and the documented role of glutamate in their regulation, we examined the effects of an increase in glutamate transport on central amplification of stress-induced bladder hyperalgesia, a core feature of IC/BPS. METHODS: Wistar-Kyoto rats were exposed to water avoidance stress (WAS, 1 hour/day x 10 days) or sham stress, with subgroups receiving daily administration of ceftriaxone (CTX), an activator of glutamate transport. Thereafter, cystometrograms were obtained during bladder infusion with visceromotor responses (VMR) recorded simultaneously. Cerebral blood flow (CBF) mapping was performed by intravenous injection of [14 C]-iodoantipyrine during passive bladder distension. Regional CBF was quantified in autoradiographs of brain slices and analyzed in three dimensional reconstructed brains with statistical parametric mapping. RESULTS: WAS elicited visceral hypersensitivity during bladder filling as demonstrated by a decreased pressure threshold and VMR threshold triggering the voiding phase. Brain maps revealed stress effects in regions noted to be responsive to bladder filling. CTX diminished visceral hypersensitivity and attenuated many stress-related cerebral activations within the supraspinal micturition circuit and in overlapping limbic and nociceptive regions, including the posterior midline cortex (posterior cingulate/anterior retrosplenium), somatosensory cortex, and anterior thalamus. CONCLUSIONS: CTX diminished bladder hyspersensitivity and attenuated regions of the brain that contribute to nociceptive and micturition circuits, show stress effects, and have been reported to demonstrated altered functionality in patients with IC/BPS. Glutamatergic pharmacologic strategies modulating stress-related bladder dysfunction may be a novel approach to the treatment of IC/BPS.
AIMS: Emotional stress plays a role in the exacerbation and development of interstitial cystitis/bladder pain syndrome (IC/BPS). Given the significant overlap of brain circuits involved in stress, anxiety, and micturition, and the documented role of glutamate in their regulation, we examined the effects of an increase in glutamate transport on central amplification of stress-induced bladder hyperalgesia, a core feature of IC/BPS. METHODS: Wistar-Kyoto rats were exposed to water avoidance stress (WAS, 1 hour/day x 10 days) or sham stress, with subgroups receiving daily administration of ceftriaxone (CTX), an activator of glutamate transport. Thereafter, cystometrograms were obtained during bladder infusion with visceromotor responses (VMR) recorded simultaneously. Cerebral blood flow (CBF) mapping was performed by intravenous injection of [14 C]-iodoantipyrine during passive bladder distension. Regional CBFwas quantified in autoradiographs of brain slices and analyzed in three dimensional reconstructed brains with statistical parametric mapping. RESULTS:WAS elicited visceral hypersensitivity during bladder filling as demonstrated by a decreased pressure threshold and VMR threshold triggering the voiding phase. Brain maps revealed stress effects in regions noted to be responsive to bladder filling. CTX diminished visceral hypersensitivity and attenuated many stress-related cerebral activations within the supraspinal micturition circuit and in overlapping limbic and nociceptive regions, including the posterior midline cortex (posterior cingulate/anterior retrosplenium), somatosensory cortex, and anterior thalamus. CONCLUSIONS: CTX diminished bladder hyspersensitivity and attenuated regions of the brain that contribute to nociceptive and micturition circuits, show stress effects, and have been reported to demonstrated altered functionality in patients with IC/BPS. Glutamatergic pharmacologic strategies modulating stress-related bladder dysfunction may be a novel approach to the treatment of IC/BPS.
Authors: Peter T Nguyen; Daniel P Holschneider; Jean-Michel I Maarek; Jun Yang; Mark A Mandelkern Journal: Neuroimage Date: 2004-09 Impact factor: 6.556
Authors: G B C Hall; M V Kamath; S Collins; S Ganguli; R Spaziani; K L Miranda; A Bayati; J Bienenstock Journal: Neurogastroenterol Motil Date: 2009-12-11 Impact factor: 3.598
Authors: Christian Twiss; Lisa Kilpatrick; Michelle Craske; C A Tony Buffington; Edward Ornitz; Larissa V Rodríguez; Emeran A Mayer; Bruce D Naliboff Journal: J Urol Date: 2009-03-14 Impact factor: 7.450
Authors: Lior Lowenstein; Kimberly Kenton; Elizabeth R Mueller; Linda Brubaker; Mary Heneghan; Judith Senka; Mary Pat Fitzgerald Journal: Neurourol Urodyn Date: 2009 Impact factor: 2.696
Authors: Jason J Kutch; Moheb S Yani; Skulpan Asavasopon; Daniel J Kirages; Manku Rana; Louise Cosand; Jennifer S Labus; Lisa A Kilpatrick; Cody Ashe-McNalley; Melissa A Farmer; Kevin A Johnson; Timothy J Ness; Georg Deutsch; Richard E Harris; A Vania Apkarian; Daniel J Clauw; Sean C Mackey; Chris Mullins; Emeran A Mayer Journal: Neuroimage Clin Date: 2015-06-05 Impact factor: 4.881